Sunnyvale, CA, United States of America

Congxin Liang

USPTO Granted Patents = 42 

 

 

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 367(Granted Patents)


Location History:

  • Sunnyvale, CA (US) (2003 - 2009)
  • Jupiter, FL (US) (2006 - 2009)
  • Palm Beach Gardens, FL (US) (2010 - 2024)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
42 patents (USPTO):

Title: Congxin Liang: Innovations in Kinase Inhibitor Compounds

Introduction: Congxin Liang is an accomplished inventor based in Sunnyvale, California, known for his significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 42 patents, Liang focuses on developing innovative compounds that serve as essential components in therapeutic applications.

Latest Patents: Liang's recent developments include groundbreaking inventions such as "Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof." This invention reveals various crystalline forms of a compound that maintains high crystalline and chemical stability, with purity levels under 2%. The efficient preparation method enables large-scale production, demonstrating its practical applications in the pharmaceutical industry. Additionally, another key patent involves a "Synthesis method of furoimidazopyridine compound," which details the synthesis of a selective JAK1/TYK2 kinase inhibitor. This method, featuring mild reaction conditions and high yields, further establishes Liang's expertise in producing compounds essential for drug development.

Career Highlights: Liang's career has included significant roles at Sugen Incorporated and Xcovery Holding Company LLC, where he has been instrumental in advancing drug discovery and development processes. His expertise in medicinal chemistry and pharmaceutical formulation has led to innovative solutions that enhance therapeutic efficacy.

Collaborations: Throughout his career, Liang has collaborated with notable professionals including Peng Cho Tang and Li Hsiang Sun. These partnerships have fostered an environment of creativity and innovation, contributing to the advancement of new therapeutic compounds.

Conclusion: Congxin Liang continues to push the boundaries of pharmaceutical science through his inventions and collaborations. His work on kinase inhibitors and their forms showcases not only his innovative spirit but also his commitment to improving healthcare outcomes. As he advances in his career, Liang's contributions remain vital to the future of drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…